Dr Michael Slater

Honorary Associate
Physiology, School of Medical Sciences

Telephone 9351 5161

Map

Selected grants

2004

  • Human prostate disease: early diagnosis of disease in the ageing human prostate; Murphy C, Slater M; Rebecca L Cooper/Medical Research Foundation.

2001

  • The production and marketing of a diagnostic kit to identify the presence and developmental rate of preneoplasia etc.; National Health and Medical Research Council (NHMRC)/Established Career Fellowships.

2000

  • Human prostrate cancer: early diagnosis of disease in the ageing prostrate; Murphy C, Slater M; Rebecca L Cooper/Medical Research Foundation.
  • A new technique for the diagnosis, staging and etiological investigation of prostate disease; Slater M; Perpetual Foundation (Perpetual Trustees)/Research Grant.
  • Does epidermal growth factor control implantation via an estrogen response element? - a fluorescence microscopy study; Slater M; Clive & Vera Ramaciotti Foundation/Project Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Slater, M., Lauer, C., Gidley-Baird, A., Barden, J. (2005). Markers for the development of early prostate cancer. In Hayat M (Eds.), Handbook of Immunohistochemistry & in situ Hybridization of Human Carcinomas, Vol. 2 (Molecular Pathology, Colorectal Carcinoma and Prostate Carcinoma), (pp. 335-346). New York: Elsevier.

Journals

  • Rybchyn, M., Slater, M., Conigrave, A., Mason, R. (2011). An Akt-dependent increase in canonical Wnt Signalling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts. Journal of Biological Chemistry, 286(27), 23771-23779. [More Information]
  • Slater, M., Cooper, M., Murphy, C. (2007). The cytoskeletal proteins alpha-actinin, Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Applied Immunohistochemistry and Molecular Morphology, 15(2), 170-174. [More Information]
  • Slater, M., Murphy, C. (2006). Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval. Journal of Molecular Histology, 37(1-2), 37-41. [More Information]
  • Slater, M., Cooper, M., Murphy, C. (2006). Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma. Acta histochemica, 108(1), 13-18. [More Information]
  • Gupta, R., Dixon, K., Deo, S., Holliday, C., Slater, M., Halliday, G., Reeve, V., Mason, R. (2006). Photoprotection by 1,25 Dihydroxyvitamin D3 Is Associated with an Increase in p53 and a Decrease in Nitric Oxide Products. Journal of Investigative Dermatology. [More Information]
  • Reeve, V., Titmuss (nee Domanski), D., Slater, M. (2006). Radiation sources providing increased UVA/UVB ratios induce photoprotection dependent on the UVA dose in hairless mice. Photochemistry and Photobiology, 82(2), 406-411. [More Information]
  • Slater, M., Cooper, M., Murphy, C., Watson, G. (2005). Adehesion molecules in endometriosis and Endometrioid adenocarcinoma show altered expressions suggesting a commonality between these diseases. Journal of Histotechnology, 28(3), 185-190.
  • Slater, M., Barden, J. (2005). Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology, 47(2), 170-178. [More Information]
  • Slater, M., Quagliotto, G., Cooper, M., Murphy, C. (2005). Endometriotic cells exhibit metaplastic change and oxidative DNA damage as well as decreased function, compared to normal endometrium. Journal of Molecular Histology, 36(4), 257-263. [More Information]
  • Slater, M., Danieletto, S., Barden, J. (2005). Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. Journal of Molecular Histology, 36(3), 159-165. [More Information]
  • Dixon, K., Deo, S., Wong, G., Slater, M., Norman, A., Bishop, J., Posner, G., Ishizuka, S., Halliday, G., Reeve, V., Mason, R. (2005). Skin cancer prevention: A possible role of 1,25dihydroxyvitamin D3 and its analogs. Journal of Steroid Biochemistry and Molecular Biology, 97(1-2), 137-143. [More Information]
  • Slater, M., Danieletto, S., Pooley, M., Teh, L., Gidley-Baird, A., Barden, J. (2004). Differentiation Between Cancerous And Normal Hyperplastic Lobules In Breast Lesions. Breast Cancer Research and Treatment, 83(1), 1-10.
  • Slater, M., Danieletto, S., Gidley-Baird, A., Teh, L., Barden, J. (2004). Early Prostate Cancer Detected Using Expression Of Non-Functional Cytolytic P2X7 Receptors. Histopathology, 44(3), 206-215.
  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(2), 137-145.
  • Slater, M., Lauer, C., Gidley-Baird, A., Barden, J. (2003). Markers for the development of early prostate cancer. Journal of Pathology, 199(3), 368-377. [More Information]
  • Slater, M., Brown, D., Husband, A. (2002). In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor B and E - cadherin expression decrease transforming growth factor B1. Prostate Cancer and Prostatic Diseases, 5(1), 16-21.
  • Slater, M., Husband, A., Brown, D. (2002). In the prostatic epithelium, dietry isoflavones from red clover significantly increase estrogen receptorB and E-cadherin expression but decrease transforming growth factor B1. Prostate Cancer and Prostatic Diseases, 5(1), 16-21.
  • Ray, F., Huang, W., Slater, M., Barden, J. (2002). Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis, 162(1), 55-61.
  • Slater, M., Murphy, C., Barden, J. (2002). Purinergic receptor expression in the apical plasma membrane of rat uterine eithelial cells during implantation. Cell Calcium, 31(5), 201-207.
  • Slater, M., Murphy, C., Barden, J. (2002). Tenascin, E-cadherin. Journal of Molecular Histology, 34(1-2), 13-19.
  • Slater, M., Murphy, C., Barden, J., Delprado, W. (2001). Detection of preneoplasia in histologically normal prostate biopsies. Prostate Cancer and Prostatic Diseases, 4 (2), 92-96.

2011

  • Rybchyn, M., Slater, M., Conigrave, A., Mason, R. (2011). An Akt-dependent increase in canonical Wnt Signalling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts. Journal of Biological Chemistry, 286(27), 23771-23779. [More Information]

2007

  • Slater, M., Cooper, M., Murphy, C. (2007). The cytoskeletal proteins alpha-actinin, Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Applied Immunohistochemistry and Molecular Morphology, 15(2), 170-174. [More Information]

2006

  • Slater, M., Murphy, C. (2006). Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval. Journal of Molecular Histology, 37(1-2), 37-41. [More Information]
  • Slater, M., Cooper, M., Murphy, C. (2006). Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma. Acta histochemica, 108(1), 13-18. [More Information]
  • Gupta, R., Dixon, K., Deo, S., Holliday, C., Slater, M., Halliday, G., Reeve, V., Mason, R. (2006). Photoprotection by 1,25 Dihydroxyvitamin D3 Is Associated with an Increase in p53 and a Decrease in Nitric Oxide Products. Journal of Investigative Dermatology. [More Information]
  • Reeve, V., Titmuss (nee Domanski), D., Slater, M. (2006). Radiation sources providing increased UVA/UVB ratios induce photoprotection dependent on the UVA dose in hairless mice. Photochemistry and Photobiology, 82(2), 406-411. [More Information]

2005

  • Slater, M., Cooper, M., Murphy, C., Watson, G. (2005). Adehesion molecules in endometriosis and Endometrioid adenocarcinoma show altered expressions suggesting a commonality between these diseases. Journal of Histotechnology, 28(3), 185-190.
  • Slater, M., Barden, J. (2005). Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology, 47(2), 170-178. [More Information]
  • Slater, M., Quagliotto, G., Cooper, M., Murphy, C. (2005). Endometriotic cells exhibit metaplastic change and oxidative DNA damage as well as decreased function, compared to normal endometrium. Journal of Molecular Histology, 36(4), 257-263. [More Information]
  • Slater, M., Danieletto, S., Barden, J. (2005). Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. Journal of Molecular Histology, 36(3), 159-165. [More Information]
  • Slater, M., Lauer, C., Gidley-Baird, A., Barden, J. (2005). Markers for the development of early prostate cancer. In Hayat M (Eds.), Handbook of Immunohistochemistry & in situ Hybridization of Human Carcinomas, Vol. 2 (Molecular Pathology, Colorectal Carcinoma and Prostate Carcinoma), (pp. 335-346). New York: Elsevier.
  • Dixon, K., Deo, S., Wong, G., Slater, M., Norman, A., Bishop, J., Posner, G., Ishizuka, S., Halliday, G., Reeve, V., Mason, R. (2005). Skin cancer prevention: A possible role of 1,25dihydroxyvitamin D3 and its analogs. Journal of Steroid Biochemistry and Molecular Biology, 97(1-2), 137-143. [More Information]

2004

  • Slater, M., Danieletto, S., Pooley, M., Teh, L., Gidley-Baird, A., Barden, J. (2004). Differentiation Between Cancerous And Normal Hyperplastic Lobules In Breast Lesions. Breast Cancer Research and Treatment, 83(1), 1-10.
  • Slater, M., Danieletto, S., Gidley-Baird, A., Teh, L., Barden, J. (2004). Early Prostate Cancer Detected Using Expression Of Non-Functional Cytolytic P2X7 Receptors. Histopathology, 44(3), 206-215.

2003

  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(2), 137-145.
  • Slater, M., Lauer, C., Gidley-Baird, A., Barden, J. (2003). Markers for the development of early prostate cancer. Journal of Pathology, 199(3), 368-377. [More Information]

2002

  • Slater, M., Brown, D., Husband, A. (2002). In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor B and E - cadherin expression decrease transforming growth factor B1. Prostate Cancer and Prostatic Diseases, 5(1), 16-21.
  • Slater, M., Husband, A., Brown, D. (2002). In the prostatic epithelium, dietry isoflavones from red clover significantly increase estrogen receptorB and E-cadherin expression but decrease transforming growth factor B1. Prostate Cancer and Prostatic Diseases, 5(1), 16-21.
  • Ray, F., Huang, W., Slater, M., Barden, J. (2002). Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis, 162(1), 55-61.
  • Slater, M., Murphy, C., Barden, J. (2002). Purinergic receptor expression in the apical plasma membrane of rat uterine eithelial cells during implantation. Cell Calcium, 31(5), 201-207.
  • Slater, M., Murphy, C., Barden, J. (2002). Tenascin, E-cadherin. Journal of Molecular Histology, 34(1-2), 13-19.

2001

  • Slater, M., Murphy, C., Barden, J., Delprado, W. (2001). Detection of preneoplasia in histologically normal prostate biopsies. Prostate Cancer and Prostatic Diseases, 4 (2), 92-96.

To update your profile click here. For support on your academic profile contact .